Exosomes and Microfluidic Tech Dominate in-cosmetics Global 2026 — South Korea Refreshes 18 Testing Standards

Exosomes and Microfluidic Tech Dominate in-cosmetics Global 2026 — South Korea Refreshes 18 Testing Standards

The skincare formulation landscape saw major developments in April and early May 2026, marked by the conclusion of in-cosmetics Global in Paris, a significant regulatory refresh from South Korea, and accelerating innovation in delivery systems and bioactive ingredients. Here is your briefing on the developments shaping cosmetic science today.

in-cosmetics Global 2026 Concludes in Paris: Inner Beauty and Exosome Tech Take Center Stage

The world’s largest personal care ingredients trade show, in-cosmetics Global 2026, wrapped up on April 16 at the Paris Expo Porte de Versailles. With over 780 exhibitors and nearly 29,000 visitors from 118+ countries, the event centered on four key themes: innovation, sustainability, inner beauty, and fragrance. A highlight was the debut of the “Beauty from Within Zone,” where companies like Gelita, AstaReal, PharmaLinea, and BASF showcased nutricosmetic solutions — from powdered hydration supplements to ingestible skincare formats. The nutricosmetics supplement market is reportedly growing at 17% annually, reflecting rising consumer appetite for holistic, inside-out approaches to skin health. Also prominent: hyaluronic acid innovations from Asian suppliers, microfluidic encapsulation technologies, and a strong push toward biodegradable, sustainable raw materials.

Full Showguide Review → | On-the-Ground Report →

South Korea Adds 18 New Ingredient Analytical Methods; Triclosan and Zinc Pyrithione Tests Revised

On April 21, 2026, South Korea’s National Institute of Food and Drug Safety Evaluation (NIFDS) published a draft revision of the “Guidelines for Analytical Methods for Cosmetic Usage Limit Ingredients” through the Korea Cosmetic Association (KCIA). The update introduces 18 new analytical methods for restricted cosmetic ingredients and improves existing testing protocols for triclosan and zinc pyrithione — two widely scrutinized preservatives. The public comment window closed April 24. For formulators targeting the Korean and broader Asian markets, staying on top of K-beauty regulatory shifts remains critical as testing requirements grow more granular and ingredient-specific.

CIRS Regulatory Summary →

Exosomes, Signal Peptides, and DNA Repair Enzymes: 2026’s Top Five Ingredient Frontiers

Exosomes — extracellular vesicles that function as intercellular messengers — have emerged as the defining ingredient story of 2026. Originally developed in regenerative medicine, exosome technology is now being applied in prestige skincare to deliver targeted repair signals directly to damaged cells, showing particular promise for post-procedure recovery and compromised barrier repair. Alongside exosomes, four other bioactives are gaining momentum: upgraded signal peptides capable of mimicking microneedling effects without skin disruption; thiotaurine, a dual-action antioxidant and anti-glycation agent; high-purity ectoin for barrier resilience; and Arabidopsis thaliana extract, a plant-derived DNA repair enzyme that intervenes in UV damage before visible signs of aging appear. The common thread: biology-inspired precision over blanket actives.

2026 Ingredient Deep-Dive →

ICIC 2026 Shanghai: Microfluidic Suspension Technology and New Group Standards for Oil-Pearl Essence

At the 2026 International Cosmetic Innovation Conference (ICIC) in Shanghai, microfluidic suspension oil-lock technology took the spotlight as a breakthrough in biphasic formulation. The technology encapsulates high-activity oils within a water phase via precision microfluidic control, creating a stable “oil-in-water” pearl structure that preserves potency and improves sensory experience. A new group standard — “Technical Specification for Oil-Based Pearl Essence Water for Skincare” — was also unveiled at the conference, establishing industry benchmarks for this emerging product category. The standard addresses formulation stability, active ingredient retention, and efficacy testing methodology, reflecting China’s growing influence in setting global cosmetic technical norms.

ICIC 2026 Report →

Next-Generation Delivery Systems: From Liposomes to AI-Assisted Formulation

2026 is shaping up as a pivotal year for transdermal delivery innovation. Liposome technology has entered its third generation, with refined vesicle structures achieving deeper stratum corneum penetration while maintaining stability in complex formulations. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are transitioning from academic research into commercial product pipelines, particularly for antioxidant and peptide delivery. Meanwhile, AI-assisted formulation design is graduating from experimental to operational — with platforms now incorporating global regulatory databases spanning 9,000+ ingredients and 200+ country-specific rules, enabling real-time compliance checking during the R&D phase. This convergence of advanced carrier systems and computational design tools is compressing development cycles while improving bioavailability and claim substantiation.

Skin Absorption Technology Report 2026 →

Disclaimer: This briefing is automatically aggregated by Melasyl AI from publicly available sources for informational purposes only. Melasyl does not verify the accuracy of third-party content. Always consult official regulatory sources and peer-reviewed research for formulation decisions.